Outcome of Double-Filtration Plasmapheresis plus Interferon Treatment in Nonresponders to Pegylated Interferon plus Ribavirin Combination Therapy

By  

Digestive Diseases, Vol. 31, Iss. 5-6, 2013-11 ,pp. : 434-439

Karger

Access to resources Recommend Favorite

Interferon Alfacon-1 and Ribavirin Versus Interferon α-2b and Ribavirin in the Treatment of Chronic Hepatitis C

By Sjogren Maria   Sjogren Robert   Holtzmuller Kent   Winston Bradley   Butterfield Betty   Drake Stanley   Watts Amber   Howard Robin   Smith Milton  

Digestive Diseases and Sciences, Vol. 50, Iss. 4, 2005-04 ,pp. : 727-732

Springer Publishing Company

Access to resources Recommend Favorite

Antiviral Response of HCV Genotype 1 to Consensus Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin

By Sjogren Maria   Sjogren Robert   Lyons Michael   Ryan Michael   Santoro John   Smith Coleman   Reddy K.   Bonkovsky Herbert   Huntley Brooke   Faris-Young Sima  

Digestive Diseases and Sciences, Vol. 52, Iss. 6, 2007-06 ,pp. : 1540-1547

Springer Publishing Company

Access to resources Recommend Favorite

Factors of Response to Pegylated Interferon/Ribavirin Combination Therapy and Mechanism of Viral Clearance

By  

Digestive Diseases, Vol. 31, Iss. 5-6, 2013-11 ,pp. : 421-425

Karger

Access to resources Recommend Favorite

A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C

By Gramenzi Annagiulia   Andreone Pietro   Cursaro Carmela   Verucchi Gabriella   Boccia Sergio   Giacomoni Pier Luigi   Galli Silvia   Furlini Giuliano   Biselli Maurizio   Lorenzini Stefania   Attard Luciano   Bonvicini Fiorenza   Bernardi Mauro  

Journal of Gastroenterology, Vol. 42, Iss. 5, 2007-05 ,pp. : 362-367

Springer Publishing Company

Access to resources Recommend Favorite